Evaluation of New Diagnostic Methods of Cardio-embolic Related (Atrial Fibrillation) Cerebral Infarction (IRMA2)
Sponsor: Hopital Foch
Terminated
Difficulty in recruiting patients
A NA clinical study on Stroke, this trial is terminated or withdrawn. The trial is conducted by Hopital Foch and has accumulated 10 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Mar 2021 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Sep 2020 — Nov 2020 [monthly]
Recruiting NA
-
Sep 2019 — Sep 2020 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2019 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Mar 2018 [monthly]
Not Yet Recruiting NA
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hopital Foch
For direct contact, visit the study record on ClinicalTrials.gov .